ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth
HEILBRONN, Germany, Sept. 21, 2022 /PRNewswire/ — ProtaGene GmbH, a leading global contract research organization focused on advanced analytics in biologics and cell and gene therapy, announced today the appointment of Raymond Kaiser, Ph.D., as Chief Executive Officer. Ray will drive the…
Comments Off on ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth